News & Events
November 6, 2017 - November 7, 2017
Proceedings from Huntington’s Disease Regulatory Science Consortium (HD-RSC) Kick-Off Meeting, Nov. 6-7, 2017On November 6 and 7, 2017, in Silver Spring, MD, Critical Path Institute and CHDI Foundation welcomed participants from the pharmaceutical industry, academia, regulatory agencies, and advocacy groups to a kick-off meeting for the Huntington’s Disease Regulatory Science Consortium (HD-RSC). The meeting objectives were to solicit input from stakeholders on HD-RSC plans and deliverables, and...
September 26, 2017
Coalition Against Major Diseases 2017 Annual Meeting and Regulatory Science WorkshopSeptember 26, 2017 Overview and Objectives: The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at developing creating Drug Development Tools that can be applied to increase the efficiency of the development process of new treatments for Alzheimer disease (AD) and related dementias. The annual meeting, which is open to the public, brings...
- June 14, 2017 - June 15, 2017
June 12, 2017
Critical Path for Parkinson’s Consortium 2017 Annual MeetingThe Critical Path for Parkinson’s (CPP) Consortium, cofounded by C-Path and Parkinson’s UK, held its second annual consortium member meeting on June 12 in Bethesda, MD. The meeting brought together scientists from the biopharmaceutical industry, academic institutions, and government agencies; people living with Parkinson’s; patient-advocacy associations; and U.S. Food and Drug Administration regulators to align on the...
June 6, 2017 - June 7, 2017
Drug-Induced Liver Injury (DILI) Conference XVIIAsymmetry of Drug Safety and Efficacy in Clinical Trials with DILI- Toward Quantitative Estimate of Net Benefit to Patients June 6, 2017 – June 7, 2017 College Park Marriott Hotel and Conference Center Paul Watkins, Mark Avigan, John-Michael Sauer, Arie Regev, Gyongyi Szabo, John Senior Drug-induced liver injury (DILI) is a major problem for drug...